BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16521178)

  • 1. Liver cirrhosis and arterial hypertension.
    Henriksen JH; Moller S
    World J Gastroenterol; 2006 Feb; 12(5):678-85. PubMed ID: 16521178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial hypertension and chronic liver disease.
    Henriksen JH; Møller S
    Minerva Med; 2005 Aug; 96(4):233-46. PubMed ID: 16179891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and liver disease.
    Henriksen JH; Møller S
    Curr Hypertens Rep; 2004 Dec; 6(6):453-61. PubMed ID: 15527691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.
    Henriksen JH; Fuglsang S; Bendtsen F; Møller S
    Gut; 2006 Mar; 55(3):380-7. PubMed ID: 16474108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects.
    Møller S; Henriksen JH
    Semin Nephrol; 1997 Nov; 17(6):505-19. PubMed ID: 9353862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Can J Gastroenterol; 2001 Feb; 15(2):94-106. PubMed ID: 11240379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamics and fluid retention in liver disease.
    Henriksen JH; Møller S
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):320-32. PubMed ID: 9759606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture.
    Gentilini P; Romanelli RG; Laffi G; Barletta G; Del Bene R; Messeri G; La Villa G
    J Hepatol; 1999 Apr; 30(4):632-8. PubMed ID: 10207804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
    Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E; Ginès P
    Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive substances in the circulatory dysfunction of cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Clin Lab Invest; 2001; 61(6):421-9. PubMed ID: 11681531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic alterations in liver cirrhosis.
    La Villa G; Gentilini P
    Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis.
    Di Pascoli M; Sacerdoti D; Pontisso P; Angeli P; Bolognesi M
    J Vasc Res; 2017; 54(2):92-99. PubMed ID: 28402977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulatory dysfunction syndrome associated with liver cirrhosis].
    Hartleb M
    Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.